Halozyme Therapeutics
HALO
#1870
Rank
A$15.70 B
Marketcap
A$137.76
Share price
-1.82%
Change (1 day)
27.26%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): A$5.13

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is A$5.31. In 2025 the company made an earnings per share (EPS) of A$3.94 a decrease over its 2024 EPS that were of A$5.28.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.1330.41%
2025A$3.94-25.43%
2024A$5.28
2022A$2.23-48.07%
2021A$4.30196.88%
2020A$1.45-292%
2019A-$0.75-9.09%
2018A-$0.83-237.5%
2017A$0.60-149.38%
2016A-$1.22211.54%
2015A-$0.39-52.73%
2014A-$0.83-24.66%
2013A-$1.1048.98%
2012A-$0.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.07-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.58 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.99-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$2.13-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A-$0.20-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA